Exploring potato extract as a multifunctional drug carrier
Keywords:
potato extract, network pharmacology, molecular docking, drug carrier, anti-cancer mechanismAbstract
As the fourth largest food crop in the world, potato contains abundant bioactive components such as polysaccharides, flavonoids and alkaloids. With natural low toxicity, degradability and structural modifiability, potato extract can serve as an efficient drug carrier. Current cancer chemotherapy is challenged by multidrug resistance, poor biocompatibility of synthetic carriers and insufficient targeting. Developing a green and intelligent drug delivery system using potato extract can break through clinical bottlenecks and realize high-value utilization of agricultural products, showing important scientific and application value.
Methods. This study adopted a combined strategy of network pharmacology, molecular docking and ADME/T prediction. Anti-cancer targets of quercetin, α-solanine and chlorogenic acid were screened via databases including SwissTargetPrediction. The component-target-pathway network was constructed with Cytoscape. Molecular docking was performed using CB-Dock2 to verify the binding modes of key compounds and core targets. Drug-likeness and toxicity risks were evaluated by SwissADME to systematically reveal the multi-target mechanism of potato extract.
Results. Three key components in potato extract exerted synergistic anti-cancer effects through multiple pathways: quercetin targeted PI3K, EGFR and other proteins to regulate tumor proliferation and apoptosis; α-solanine acted on TOP2A and ACHE to induce DNA damage and promote apoptosis; chlorogenic acid targeted AKT1 and MAOA to reverse drug resistance, exert anti-inflammation and neuroprotection. Molecular docking confirmed stable binding and strong affinity of key complexes. ADME/T prediction indicated favorable drug-likeness. The three-dimensional network structure of the carrier enabled efficient drug loading, controlled release and obvious tumor targeting.
Conclusion. Potato extract can be used as a multifunctional natural drug carrier, which inhibits tumors and reverses drug resistance via multi-target and multi-pathway synergistic mechanisms. Its drug delivery system has excellent biocompatibility and targeting ability. This study provides a universal analytical framework for developing natural plant-derived drug systems and theoretical support for high-value utilization of potatoes and green anti-cancer drug research. Further in vitro and in vivo verification and structural optimization of α-solanine are needed to reduce toxicity.
References
Zhao M. et al. (2023). Structural characterization and antitumor activity of a novel polysaccharide from solanum tuberosum. Carbohydrate polymers, 301, 120358.
Wang Y. et al. (2022). Potato-derived nanoparticles as biocompatible carriers for doxorubicin: A phresponsive drug delivery system. Journal of nanobiotechnology, 20(1), 1-15.
Saeed M. E. M. et al. (2021). P-glycoprotein inhibition by natural products: A novel approach to overcome multidrug resistance in cancer. Pharmacological research, 170, 105750.
Singh R. & Kaur l. (2021). Traditional uses and modern perspectives of potato in medicine: A review. Journal of ethnopharmacology, 275, 113932.
Daina A, Michielin O. & Zoete V. (2019). Swisstargetprediction: Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic acids research, 47 (w1), w357 - w364.
Shannon, P., Markiel, A., Ozier, O, Baliga, N. S., Wang, J. T, Ramage, D. & Kitano, H. (2003). Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome research, 13(11), 2498-2504.
Szklarczyk D., Gable A. L., lyon D., Junge, A., Wyder,S., Huerta-cepas J. & Jensen l. J. (2019). String v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic acids research, 47 (d1), d607-d613.
Kitchen D. B., Decornez H., Furr J. R. & Bajorath, J. (2004). Docking and scoring in virtual screening for drug discovery: Methods and applications. Nature reviews drug discovery, 3 (11), 935 – 949.
Morley S. D. & Keiser M. J. (2018). Molecular docking: An overview of methods, applications and recent advances. British journal of pharmacology, 175 (18), 3562 – 3580.
Daina A., Michielin O. & Zoete V. (2017). Swissadme: A free web tool to evaluate pharmacokinetics, drug – likeness and medicinal chemistry friendliness of small molecules. Scientific reports, 7 (1), 42717.
Lipinski C. A., Lombardo F., Dominy B. W. & Feeney P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced drug delivery reviews, 23 (1 - 3), 3 – 25.
Li, X. & Zhang Y. (2022). Inhibition of p – glycoprotein by phenolic compounds in potato extracts: A molecular docking and experimental study. Chinese journal of natural medicines, 20 (12), 981 – 990.
Wang X. & Li, Y. (2023). Overcoming multidrug resistance in cancer cells using potato - extract - based drug delivery systems: A preclinical study. Journal of hematology & oncology, 16 (1), 1 - 15.
Torchilin V. P. (2011). Tumor - targeting delivery of antitumor drugs using tumor - penetrating peptides. Proceedings of the national academy of sciences, 108 (27), 10982 - 10989.
Matsumura Y. & Maeda, H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer research, 46 (12), 6387 - 6392.
Hanahan D. & Weinberg R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144 (5), 646 - 674.
Schipper M. L. & De vries I. J. (2016). Mouse models of cancer for preclinical studies of targeted therapies. British journal of cancer, 114 (8), 835 – 843.
